Themed VHIO in 2015: Tackling a Constellation of Challenges to Conquer Cancer, we are pleased to announce that our 2015 Scientific Report is now available.
Read moreThe study, which uses Saccharomyces cerevisiae (beer yeast) as a model organism, is an important step towards the development of therapies that prevent tumor cells from replicating.
Read moreThe expression of a central regulator of cell metabolism, PGC1A is associated with prostate cancer aggressiveness. The research paves the way for the identification of patients at risk of developing m...
Read moreSe trata de evitar o minimizar la angustia del paciente con nódulos tiroideos ante la posibilidad de padecer un cáncer de tiroides al mantenerse a la espera del diagnóstico.
Read moreThe research explains how the protein cyclin D1 regulates the process of cell invasion and the importance of this mechanism in tumor invasion
Read moreHis research showed that phenotypic diversity can be explained not only by genetics and environmental conditions but also by stochastic variances in gene expression. He then explored other aspects on ...
Read moreResearchers from the Hospital del Mar Medical Research Institute (IMIM) have, for the first time, demonstrated that measurements of a tobacco-specific nitrosamine in the hair, NNK, correlate with the ...
Read moreA pesar de las pruebas ya existentes que establecen una relación directa entre la producción de aluminio y la aparición de cáncer de vejiga y de pulmón, el riesgo a sufrir cáncer en la indust...
Read moreEl Hospital Virgen de la Victoria, el Laboratorio de Fotobiología Dermatológica del Centro de Investigaciones Médicas de la Universidad de Málaga (CIMES) y el Hospital Universitario Gómez Ulla de...
Read moreLa Obra Social “la Caixa” impulsa este simposio, en el que se debatirá sobre las capacidades y limitaciones de los modelos preclínicos actuales con los que se investigan tratamientos experimenta...
Read moreThe Worldwide Cancer Research (WCR) has granted €715,000 to the Centre for Applied Medical Research (CIMA) of the University of Navarra for four projects on lymphoma, melanoma, lung cancer and breas...
Read moreCANCER Research Technology (CRT), the development and commercialisation arm of Cancer Research UK – has entered into a license agreement with Pangaea Biotech to develop p21-activated kinase (PAK) in...
Read more